HIIT and moderate cardio offer complementary approaches for patients on tirzepatide. Choosing the right type of cardiovascular training depends on your treatment phase, physical condition, and body composition goals.
HIIT vs Moderate Cardio: Definitions and Differences
HIIT (High-Intensity Interval Training) alternates phases of intense effort (85-95% of maximum heart rate) with active recovery phases. A typical session lasts 15 to 25 minutes. Moderate cardio (Zone 2) maintains a constant intensity at 60-70% of max HR for 30 to 60 minutes: brisk walking, cycling, swimming at a comfortable pace.
A meta-analysis of 77 studies published in the British Journal of Sports Medicine (2024) shows that HIIT produces 28% greater visceral fat loss than moderate cardio for half the training time. However, under GLP-1 agonists, the specific risks of HIIT must be considered.
Benefits and Risks of HIIT Under Tirzepatide
- Benefits: short sessions (15-25 min), increased post-exercise metabolism (EPOC) for 24-48h, superior insulin sensitivity improvement compared to moderate cardio, preservation of muscle mass
- Risks under GLP-1: nausea and vomiting triggered by intense effort, risk of hypoglycemia in diabetics, accelerated dehydration, excessive cardiovascular stress if physical condition is insufficient
When to Prioritize Moderate Cardio
Moderate cardio (Zone 2) is preferable in the following situations: during the first 8 weeks of treatment, during tirzepatide dose changes, on days of nausea or fatigue, for patients who have never exercised, in cases of uncontrolled cardiovascular comorbidities, and during post-HIIT recovery.
Moderate cardio offers unique advantages: it improves fat oxidation (the body preferentially uses fat as fuel at this intensity), it is well tolerated digestively, it can be practiced daily without risk of overtraining, and it improves mitochondrial health according to Dr. Peter Attia’s work.
Optimal Hybrid Program Under GLP-1
Phase 1 (weeks 1-8): 100% moderate cardio. 3-5 sessions of 30 min brisk walking, cycling, or swimming. Build a solid cardiovascular base.
Phase 2 (weeks 9-16): 80% moderate / 20% HIIT. Introduce 1 HIIT session per week (brisk walking with intervals: 30 sec fast / 90 sec slow, 8 cycles). Maintain 3-4 moderate cardio sessions.
Phase 3 (beyond 16 weeks): 60% moderate / 40% HIIT. 2 HIIT sessions + 2-3 moderate cardio sessions. Vary modalities: HIIT cycling, interval swimming, interval running.
HIIT Protocol Adapted for Patients on GLP-1
- Warm-up: 5 min progressive moderate cardio
- Intense phase: 20-30 sec effort at 80-85% max HR (not 95% like classic HIIT)
- Recovery: 60-90 sec slow walk or rest
- Repetitions: 6 to 10 cycles for a 15-20 min session
- Cool-down: 5 min slow walk + stretching
- Hydration: drink 200 ml every 10 min during the session
Intensity Monitoring
Use a heart rate monitor (smartwatch) to stay within target zones. The Borg Scale of Perceived Exertion (1 to 10) is a simple tool: moderate cardio corresponds to 4-5/10 (conversation possible), adapted HIIT to 7-8/10 (short sentences only). Under tirzepatide, never exceed 8/10 without medical supervision.
Track your progress with the MounjaGO app.
FAQ
Is HIIT recommended under Mounjaro?
HIIT can be beneficial but only after 8 weeks of treatment and in an adapted version (intensity at 80-85% instead of 95%). Start with 1 session per week, combine with moderate cardio. Avoid HIIT on days of nausea.
What is the best cardio for weight loss under tirzepatide?
The combination of both is optimal: moderate cardio (walking, cycling) for daily fat oxidation, and HIIT 1-2 times/week for post-exercise metabolism. Moderate cardio is better tolerated digestively.
How much cardio per week under GLP-1?
Minimum 150 minutes of moderate activity per week, or 5 sessions of 30 minutes. If you add HIIT, count each minute of HIIT as 2 minutes of moderate cardio (WHO equivalence).